Ira Scott Greenspan - Aug 27, 2021 Form 4 Insider Report for Scopus BioPharma Inc. (SCPS)

Role
Executive Committee Chairman, Director, 10%+ Owner
Signature
/s/ Ira Scott Greenspan
Stock symbol
SCPS
Transactions as of
Aug 27, 2021
Transactions value $
$4,475
Form type
4
Date filed
8/30/2021, 09:11 AM
Previous filing
Aug 25, 2021
Next filing
Nov 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPS Common Stock, par value $0.001 Purchase $541 +110 +0.13% $4.92* 82.5K Aug 27, 2021 Direct F1
transaction SCPS Common Stock, par value $0.001 Purchase $3.93K +790 +5.7% $4.98* 14.6K Aug 27, 2021 HCFP F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.91 to $5.00 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.96 to $5.00 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.
F3 Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein.